Innovative Drug Discovery and Development

Home Home Research Consortia Innovative Drug Discovery and Development

Gulf Coast Consortium for Innovative Drug Discovery and Development

Formerly the John S. Dunn Gulf Coast Consortium for Chemical Genomics (GCC CG) which was formed in 2003, the Consortium for Innovative Drug Discovery and Development (GCC IDDD) is a research consortium focused on providing support for Houston/Galveston scientists in advancing their therapeutics discoveries through development to the clinic. IDDD support includes collaborative networking and joint funding opportunities, shared core resources, and educational programs.

New! The Cancer Therapeutics Training Program (CTTP)

The Cancer Therapeutics Training Program (CTTP) is a multi-institutional post-doctoral training program designed to prepare post-doctoral trainees for future careers in academic and/or commercial cancer therapeutics research and development (R&D). The goal of the program is to recruit and train scientists equipped with the essential skills and knowledge necessary to translate basic cancer research discoveries into commercially viable cancer therapeutics. For more information, visit the CTTP Website.


Fannin Open House, November 10

Fannin Innovation Studio is actively seeking Therapeutics interns and has an Open House coming up on May 26th

Fannin primarily in-licenses promising, early-stage therapeutic and medical device technologies from leading academic investigators in the Texas Medical Center and on a national stage. Fannin develops and de-risks these technologies via preclinical work and engineering up through early clinical trials. Additionally, Fannin builds the business model and use case, resulting in strategic partnerships or acquisitions.

Our internship program provides hands-on operational experience in early-stage life science development. Fannin offers two tracks in our internship program: Therapeutics and Medical Devices. Our interns work closely with established and potential portfolio companies, experientially learning about biomedical commercialization. Interns might be tasked with assisting with due diligence, working on market analysis, assisting with product development, or researching and understanding key regulatory requirements. All interns work closely with the core Fannin team to ensure a beneficial and useful experience.

We have had many interns and Fellows complete our program, and we look forward to receiving interest from more of your members!


Questions? Contact Serena Miggins or Stephanie Vega


Upcoming Events

IDDD BioConnect, March 5, 2024

This month's BioConnect will occur on March 5, 2024, from 4:00-6:00 pm at Levit Green, 3131 Holcombe Houston, TX.  Please RSVP using the button below.

Find out more »

IDDD Round Table Workshop: Transitioning from Academia to Industry

This workshop will feature the following presenters: Andrea Wiley, PhDSenior Scientist, Ridgeline Therapeutics Shantanu Guha, PhDResearch Scientist, Scorpius BioManufacturing, Inc.

Find out more »

Achieving Data Quality and Integrity in Maximum Containment Laboratories – Nonclinical Course

FDA-UTMB Collaborative Education Program Course Format: In-person (at UTMB) or Virtual Course Description: The four and one-half day training program is offered annually utilizing expert faculty from the U.S. Food […]

Find out more »

Save the date: 5th Annual Gulf Coast Consortia Innovative Drug Discovery and Development Conference,

Confirmed presenters: Suga Hiroaki, Univ. of Tokyo; Jason Bock, CTMC+;  Kate Broderick, Maravai LifeSciences; Jimmy Gollihar, Houston Methodist Research Institute; Alexander Kabanov, Univ. of North Carolina, Chapel Hill; Charlene Liao, Immune-Onc Therapeutics; Michael Mitchell, Univ. of Pennsylvania; Cassian Yee, MD Anderson […]

Find out more »